Vanguard Group Inc Collegium Pharmaceutical, Inc Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Vanguard Group Inc holds 2,282,666 shares of COLL stock, worth $69.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,282,666

Previous 2,346,542 2.72%

Holding current value

$69.7 Million

Previous $90.7 Million 27.87%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$28.61 - $41.86 $1.83 Million - $2.67 Million	-63,876 Reduced 2.72%	2,282,666 $65.4 Million
Q3 2024 Nov 13, 2024	SELL	$31.4 - $39.07 $766,160 - $953,308	-24,400 Reduced 1.03%	2,346,542 $90.7 Million
Q2 2024 Aug 13, 2024	BUY	$31.36 - $39.99 $1.26 Million - $1.61 Million	40,214 Added 1.73%	2,370,942 $76.3 Million
Q1 2024 May 10, 2024	BUY	$31.23 - $40.91 $560,328 - $734,007	17,942 Added 0.78%	2,330,728 $90.5 Million
Q4 2023 Feb 14, 2024	SELL	$21.16 - $30.8 $556,719 - $810,348	-26,310 Reduced 1.12%	2,312,786 $71.2 Million
Q3 2023 Nov 14, 2023	BUY	$21.23 - $24.28 $49,656 - $56,790	2,339 Added 0.1%	2,339,096 $52.3 Million
Q2 2023 Aug 14, 2023	BUY	$21.06 - $24.0 $649,006 - $739,608	30,817 Added 1.34%	2,336,757 $50.2 Million
Q1 2023 May 15, 2023	BUY	$23.0 - $29.88 $2.25 Million - $2.92 Million	97,829 Added 4.43%	2,305,940 $55.3 Million
Q4 2022 Feb 10, 2023	SELL	$16.14 - $23.55 $1.49 Million - $2.17 Million	-92,076 Reduced 4.0%	2,208,111 $51.2 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $20.1 $398,883 - $518,600	25,801 Added 1.13%	2,300,187 $36.8 Million
Q2 2022 Aug 12, 2022	SELL	$14.22 - $20.88 $457,073 - $671,145	-32,143 Reduced 1.39%	2,274,386 $40.3 Million
Q1 2022 May 13, 2022	BUY	$17.2 - $22.5 $328,726 - $430,020	19,112 Added 0.84%	2,306,529 $47 Million
Q4 2021 Feb 14, 2022	SELL	$17.5 - $21.35 $998,637 - $1.22 Million	-57,065 Reduced 2.43%	2,287,417 $42.7 Million
Q3 2021 Nov 12, 2021	BUY	$17.75 - $25.39 $1.85 Million - $2.64 Million	104,093 Added 4.65%	2,344,482 $46.3 Million
Q2 2021 Aug 13, 2021	BUY	$21.74 - $25.28 $48.7 Million - $56.6 Million	2,240,389 New	2,240,389 $53 Million

Others Institutions Holding COLL

# of Institutions

248

Shares Held

37.5M

Call Options Held

100K

Put Options Held

10K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.04B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Collegium Pharmaceutical, Inc Transaction History